Crestor to start first multinational trials "DISCOVERY" in Korea

Published: 2003-10-20 06:59:00

Updated: 2003-10-20 06:59:00

Pharmaceutical business sources say that local DISCOVERY trials for AstraZeneca's lead product Crestor for the treatment of hyperlipidemia are now underway with the initiative of a Korean chief investigator, with an aim to compare the efficacy and safety profiles of both rosuvastatin and atorvastatin in lowering the level of cholesterol.

A total number of 1,362 patients is enrolled in the t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.